Sardona Therapeutics

sardonatx.com

Sardona Therapeutics built a leading drug discovery platform to identify new small molecules to target RNA-binding proteins (RBP) and modulate RBP-driven biology for the treatment of cancer and other diseases. The platform’s foundation is our proprietary RBP topography map that links different RBPs to specific therapy-resistant cancers. We leverage internally developed screening assays, bioinformatics capabilities, and focused small molecule compound libraries to generate best-in-class drug candidates that target individual RBPs. We also believe there are important targets and applications beyond oncology, where Sardona’s platform can identify novel drug leads.